GEXVal's Drug Repurposing Study Using GATE-Based AI Technology Published in Journal “Pharmaceuticals”
2026/9/25
GEXVal Inc. September 25, 2026 GEXVal Publishes COVID-19 Drug Repurposing Study Using Its AI Technology GATE i […]
GEXVal to Exhibit at BioJapan 2026
2026/9/25
GEXVal Inc. September 25, 2026 GEXVal to Showcase AI-Powered Drug Discovery Platform RePhaIND® at BioJapan 202 […]
GEXVal to present AI Drug Discovery Platform RePhaIND® at BioJapan Seminar
2026/9/25
GEXVal Inc. September 25, 2026 GEXVal Inc. to Present at BioJapan 2026 Seminar “From Analytical AI to Explorat […]
GEXVal CEO Invited to Speak at "Australia-Japan Innovation Alliance Forum 2026"
2026/9/18
GEXVal Inc. September 18, 2026 GEXVal CEO Invited to Speak at "Australia-Japan Innovation Alliance Forum 2026" […]
GEXVal CEO Invited to Speak at "YOKOHAMA DEEP TECH GLOBAL BRIDGE 2026"
2026/9/15
GEXVal Inc. September 15, 2026 GEXVal CEO Invited to Speak at "YOKOHAMA DEEP TECH GLOBAL BRIDGE 2026" G […]